| 1 | 13NH3 PET/CT scan | - | - | - | - | [1] 84 84 |
| 2 | 18F-DOPA PET | - | - | - | - | [1] 6 6 |
| 3 | 18FDG PET/CT scan | - | - | - | - | [1] 84 84 |
| 4 | 68Ga-DOTA-TATE PET/MR and PET/CT imaging | [1] Dotatate Dotatate | - | - | - | [1] 238 238 |
| 5 | 68Ga-DOTATATE PET/CT | [2] Dotatate Dotatate, Dotatate gallium Ga-68 | - | - | - | [1] 84 84 |
| 6 | [18F] LBT-999 PET | - | - | - | - | [1] 6 6 |
| 7 | [18F]-FLT-PET/CT scans | - | - | - | - | [1] 34 34 |
| 8 | [18F]DPA-714 PET | - | - | - | - | [1] 2 2 |
| 9 | [18F]DPA-714 PET scan | - | - | - | - | [1] 6 6 |
| 10 | [18F]FDOPA PET/CT | - | - | - | - | [1] 6 6 |
| 11 | [18F]Florbetapir PET imaging | - | - | - | - | [1] 13 13 |
| 12 | [18F]FPEB PET imaging | - | - | - | - | [1] 206 206 |
| 13 | [C11]PK-1195 PET scan | - | - | - | - | [1] 13 13 |
| 14 | [Zr-89]Oxine-labeled leukocytes PET/MR | [1] Oxyquinoline Oxyquinoline | [1] D05321
D05321
| - | - | [1] 13 13 |
| 15 | Brain PET scan | - | - | - | - | [3] 5 5, 7, 127 |
| 16 | Cellulose acetate with petrolatum | [3] Acetate Acetate, Microcrystalline cellulose, Petrolatum | [2] D00093
D00093
,
D05331
(Name: Petrolatum) | - | - | [2] 35 35, 162 |
| 17 | Combination Product: 68Ga-DOTATATE PET/CT | [2] Dotatate Dotatate, Dotatate gallium Ga-68 | - | - | - | [1] 238 238 |
| 18 | Cotton gauze with petrolatum | [2] Cotton Cotton, Petrolatum | [1] D05331
D05331
(Name: Petrolatum) | - | - | [2] 35 35, 162 |
| 19 | Diagnostic Test: 11C-UCB-J PET-CT | - | - | - | - | [1] 8 8 |
| 20 | Diagnostic Test: 18F-FDG and 68Ga-FAPI PET/CT | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [1] 96 96 |
| 21 | Diagnostic Test: 18F-FDG PET-MR | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [1] 8 8 |
| 22 | Diagnostic Test: 18F-FDG-PET/MRI | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [1] 84 84 |
| 23 | Diagnostic Test: 18F-GE180-PET/MRI | - | - | - | - | [1] 84 84 |
| 24 | Diagnostic Test: 68-Ga HA-DOTATATE PET/CT | [1] Dotatate Dotatate | - | - | - | [1] 41 41 |
| 25 | Diagnostic Test: 68Ga-DOTA-TOC PET/CT | - | - | - | - | [1] 84 84 |
| 26 | Diagnostic Test: Entire-body PET-CT scans | - | - | - | - | [1] 13 13 |
| 27 | Diagnostic Test: FDG-PET/CT with Rb82 Myocardial Perfusion Imaging | - | - | - | - | [1] 84 84 |
| 28 | Diagnostic Test: PET Imaging | - | - | - | - | [1] 85 85 |
| 29 | Diagnostic Test: PET with [11C]Flumazenil | [1] Flumazenil Flumazenil | [1] D00697
D00697
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 13 13 |
| 30 | Diagnostic Test: PET-CT Imaging with [89Zr]-bevacizumab | [1] Bevacizumab Bevacizumab | [1] D06409
D06409
| [1] VEGFA VEGFA 💬 | [24] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | [1] 86 86 |
| 31 | Diagnostic Test: simultaneous combined 18F-FDG PET and cardiac MRI imaging | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [1] 84 84 |
| 32 | DPA-714 PET/MRI | - | - | - | - | [1] 13 13 |
| 33 | DPA-714-PET/MRI | - | - | - | - | [1] 6 6 |
| 34 | ESR-specific PET scan | - | - | - | - | [1] 86 86 |
| 35 | FDG-PET | - | - | - | - | [1] 299 299 |
| 36 | GE180 PET Scan | - | - | - | - | [1] 6 6 |
| 37 | Morphine, buprenorphine, pethidine, tramaldol, metamizole and acetylsalicylacid (Analgesics) | [4] Buprenorphine Buprenorphine, Meperidine (Synonym: Petidina), Metamizole, Morphine | [8] D00836
D00836
,
D00842
,
D01383
(Name: Pethidine hydrochloride (JP18)),
D02271
,
D07132
,
D08188
,
D08233
,
D08343
(Name: Pethidine) | [2] OPRK1 OPRK1, OPRM1 💬 | [3] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | [1] 298 298 |
| 38 | MRI, FDG-PET/CT scans | - | - | - | - | [1] 34 34 |
| 39 | Other: 18F-FDG PET/CT | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [1] 41 41 |
| 40 | Other: 18F-Fluorodeoxyglucose (18F-FDG) PET/CT | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [1] 84 84 |
| 41 | Other: [11C]-Methionine PET/MRI | [1] Methionine Methionine | [2] D00019
D00019
,
D04983
| - | - | [1] 75 75 |
| 42 | Other: [11C]donepezil PET | [1] Donepezil Donepezil | [2] D00670
D00670
,
D07869
| [1] ACHE ACHE 💬 | [2] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1] 6 6 |
| 43 | PET | - | - | - | - | [1] 6 6 |
| 44 | PET with 11C-Flumazenil | [1] Flumazenil Flumazenil | [1] D00697
D00697
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 13 13 |
| 45 | PET-MRI with [18F]-Florbetaben and PET-MRI with [18F]-DPA-714 | - | - | - | - | [1] 13 13 |
| 46 | PET/CT | - | - | - | - | [1] 6 6 |
| 47 | PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714 | - | - | - | - | [1] 85 85 |
| 48 | PET10 | - | - | - | - | [1] 41 41 |
| 49 | PET3 | - | - | - | - | [1] 41 41 |
| 50 | Pethidine | [1] Meperidine Meperidine (Synonym: Petidina) | [2] D01383
D01383
(Name: Pethidine hydrochloride (JP18)),
D08343
(Name: Pethidine) | [1] OPRM1 OPRM1 💬 | [3] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | [1] 298 298 |
| 51 | Petrolatum | [1] Petrolatum Petrolatum | [1] D05331
D05331
(Name: Petrolatum) | - | - | [3] 35 35, 158, 162 |
| 52 | Radiation: 11C-MET PET/CT Imaging | - | - | - | - | [1] 53 53 |
| 53 | Radiation: 18F-FDG PET/CT Imaging | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [1] 53 53 |
| 54 | Radiation: [18-Fluorine] Flubatine PET Scan | - | - | - | - | [1] 6 6 |
| 55 | Radiation: Cardiac PET imaging using F-18-FDG, N-13 ammonia( NH3) | [1] Ammonia Ammonia | [1] D02916
D02916
| - | - | [1] 88 88 |
| 56 | Radiation: DOTATATE PET-CT | [1] Dotatate Dotatate | - | - | - | [1] 75 75 |
| 57 | Radiation: F-DOPA PET CT | - | - | - | - | [1] 75 75 |
| 58 | Radiation: FDG PET scan | - | - | - | - | [1] 85 85 |
| 59 | Radiation: H215O PET | - | - | - | - | [2] 6 6, 17 |
| 60 | Radiation: PET (Positron Emission Tomography) Study | - | - | - | - | [1] 17 17 |
| 61 | Radiation: PET with the tracer 11C-PE2I | - | - | - | - | [1] 6 6 |
| 62 | Radiation: PET with the tracer 18F-DPA-714 | - | - | - | - | [1] 6 6 |
| 63 | Radiation: PET/CT Scan | - | - | - | - | [1] 67 67 |
| 64 | Radiation: PET/CT Scan: Two PET scans using 1. C-11 HED and 2. N-13 Ammonia or rubidium-82 | [2] Ammonia Ammonia, Rubidium | [1] D02916
D02916
| - | - | [1] 86 86 |
| 65 | Radiation: PET/MR with [11C]PBR28 | - | - | - | - | [1] 6 6 |
| 66 | Radiation: Rubidium PET | [1] Rubidium Rubidium | - | - | - | [1] 84 84 |
| 67 | Radiation: Stress myocardial perfusion PET | - | - | - | - | [1] 46 46 |